rf-fullcolor.png

 

November 26, 2018
by Ana Mulero

Health Canada Proposes Changes to Priority Review Requests for Medical Devices

Health Canada intends to modify its policy for medical device manufacturers to request priority reviews by nixing its requirement on a separate submission and adding a new required criterion for eligibility.

The existing process for medical device manufacturers to request priority reviews for expedited entries to the Canada market is “still relevant” but “unnecessarily complex,” Health Canada argued in a recent notice of intent.

The conclusion was reached based on a review of the preferential prioritization system under an interim policy implemented in 2000. Consideration should also be given to unforeseen or unmet urgent health needs in granting priority reviews on license applications in addition to the criteria under the interim policy, the regulatory authority said, pointing to the newly proposed criterion for Class III and IV devices.

Further, Health Canada intends to cease requiring manufacturers to submit a separate request or form in addition to a priority review request.

“Applications requesting priority review will be screened in accordance with the standard 15 -day performance target, but reviewed in priority” when the specified criteria are met, Health Canada clarified. Industry can submit comments in response to the proposed changes until 25 January 2019.

Notice of Intent – Health Canada to confirm its priority review request process of medical device applications and eligibility criteria
×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.